Gerresheimer (BMV:GXI N) - Stock Price, News & Analysis

GXI N Stock Overview

Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. More details

GXI N fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	3/6
Past Performance	4/6
Financial Health	3/6
Dividends	3/6

Rewards

Trading at 4.7% below our estimate of its fair value

Earnings are forecast to grow 19.65% per year

Earnings grew by 20.8% over the past year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Shareholders have been diluted in the past year

Gerresheimer AG Competitors

Genomma Lab Internacional. de

BMV:LAB B

Mex$25.2b

Syngene International

NSEI:SYNGENE

₹338.2b

SCHOTT Pharma KGaA

XTRA:1SXP

€3.9b

Sotera Health

NasdaqGS:SHC

US$4.1b

Price History & Performance

Summary of all time highs, changes and price drops for Gerresheimer
Historical stock prices
Current Share Price	€1,649.75
52 Week High	€1,649.75
52 Week Low	€1,649.75
Beta	0.91
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	0%

Recent updates

Shareholder Returns

	GXI N	MX Life Sciences	MX Market
7D	0%	0%	0%
1Y	n/a	0%	0%

Return vs Industry: Insufficient data to determine how GXI N performed against the MX Life Sciences industry.

Return vs Market: Insufficient data to determine how GXI N performed against the MX Market.

Price Volatility

Is GXI N's price volatile compared to industry and market?
GXI N volatility
GXI N Average Weekly Movement	n/a
Life Sciences Industry Average Movement	0%
Market Average Movement	0%
10% most volatile stocks in MX Market	0%
10% least volatile stocks in MX Market	0%

Stable Share Price: GXI N has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine GXI N's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1864	11,660	Dietmar Siemssen	www.gerresheimer.com

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.

Gerresheimer AG Fundamentals Summary

How do Gerresheimer's earnings and revenue compare to its market cap?
GXI N fundamental statistics
Market cap	Mex$66.10b
Earnings (TTM)	Mex$2.11b
Revenue (TTM)	Mex$36.21b

31.3x

P/E Ratio

1.8x

P/S Ratio

Is GXI N overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GXI N income statement (TTM)
Revenue	€1.99b
Cost of Revenue	€1.39b
Gross Profit	€597.31m
Other Expenses	€481.19m
Earnings	€116.13m

Last Reported Earnings

Nov 30, 2023

Next Earnings Date

Apr 11, 2024

Earnings per share (EPS)	3.36
Gross Margin	30.01%
Net Profit Margin	5.83%
Debt/Equity Ratio	66.5%

How did GXI N perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

36%

Payout Ratio

Gerresheimer BMV:GXI N Stock Report